Breathe Well Live Well
|
Development of a core outcome set for clinical trials in childhood asthma: a …
7thSpace Interactive (press release) Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people – up-to-the-minute news and headlines. 7thSpace is a online portal covering topics such as Family, Business, Entertainment … |
View full post on asthma – Google News
 MD News |
Asthma treatment response reduced in obese patients
Clinical Advisor Higher levels of neutrophilic inflammation may explain why obese patients with asthma respond less to corticosteroid treatment. Obese asthma patients have reduced treatment response |
View full post on asthma – Google News
 Michigan Business Review – MLive.com |
Hundreds of clinical trials in Michigan are addressing asthma, heart …
Michigan Business Review – MLive.com Some clinical trials have trouble recruiting patients due to risks, complexity and other factors. |
View full post on asthma – Google News
|
MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma …
FierceBiotech MediciNova intends to design pivotal trial(s) that will include technological and operational improvements and further controls for medications that are not typically used in the treatment of acute exacerbations of asthma and were over-represented in … MediciNova Reports Results Of A Phase 2b Trial Of MN-221 In Asthma Exacerbations |
View full post on asthma – Google News
|
MediciNova Reports Results of a Phase 2b Clinical Trial of MN-221 in Asthma …
MarketWatch (press release) MediciNova intends to design pivotal trial(s) that will include technological and operational improvements and further controls for medications that are not typically used in the treatment of acute exacerbations of asthma and were over-represented in … MediciNova (MNOV) Says Results of Phase 2B Trial of MN-221 Didn't Meet Primary … |
View full post on asthma – Google News
|
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled …
MarketWatch (press release) "We are strongly committed to advancing a pipeline of iCALM therapies to treat chronic respiratory diseases, including COPD, asthma and cystic fibrosis." "iCALM's ability to limit allergen-induced eosinophilic airway inflammation in this trial is … |
View full post on asthma – Google News
|
Children Usually Excluded From Clinical Drug Trials: Study
MSN Health & Fitness In a new study, researchers looked at all clinical trials registered worldwide from 2006 to 2011 for drugs to treat these common conditions: asthma, migraine headaches, schizophrenia, depression, diarrheal illness, lower respiratory infection, malaria, … |
View full post on asthma – Google News
|
Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical …
Benzinga … the Founder, President and Chief Executive Officer of MediciNova, Inc. (NASDAQ: MNOV) tells investors about a promising treatment approach aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma, … |
View full post on asthma – Google News
 Daily Mail |
Positive SNG001 Phase II Asthma Clinical Trial Data
Science 2.0 (press release) This pioneering trial investigated the potential for SNG001 (inhaled interferon beta) to protect asthmatics from respiratory virus infections (principally the common cold) that can spread to the lung, which are a major cause of worsening asthma … Asthma drug 'protects sufferers from life-threatening symptoms caused by … Synairgen's 'breakthrough' asthma drug shines in Phase II trial New drug 'reduces asthma symptoms' |
View full post on asthma – Google News
|
Developer of New Treatment for Severe Asthma Episodes Expects Phase 2 Clinical …
MarketWatch (press release) … aimed at meeting the need for novel treatments for patients suffering from acute exacerbations of asthma (AEA), a long-lasting and severe form of asthma episode in which symptoms are unresponsive to initial bronchodilator or corticosteroid therapy. |
View full post on asthma – Google News